Cargando…
Genetic variation in SARS-CoV-2 may explain variable severity of COVID-19
Autores principales: | Biswas, Subrata K, Mudi, Sonchita R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246007/ https://www.ncbi.nlm.nih.gov/pubmed/32464496 http://dx.doi.org/10.1016/j.mehy.2020.109877 |
Ejemplares similares
-
Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19
por: Biswas, Subrata K., et al.
Publicado: (2020) -
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
por: Bachmann, Martin F., et al.
Publicado: (2021) -
In silico anti-SARS-CoV-2 activities of five-membered heterocycle-substituted benzimidazoles
por: Mudi, Prafullya Kumar, et al.
Publicado: (2022) -
Relationship of Soluble RAGE with Insulin Resistance and Beta Cell Function during Development of Type 2 Diabetes Mellitus
por: Biswas, Subrata Kumar, et al.
Publicado: (2015) -
Insights into genetic factors contributing to variability in SARS-CoV-2 susceptibility and COVID-19 disease severity
por: D’Antonio, Matteo, et al.
Publicado: (2021)